Marc Michel Selected Research

Inosine Triphosphate (ITP)

1/2022	Adult Evans' Syndrome.
1/2022	Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network.
1/2022	High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura.
1/2022	Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment.
1/2022	Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.
12/2021	Evans syndrome in adults: an observational multicenter study.
1/2021	Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial.
1/2021	Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life.
1/2021	Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP.
1/2021	Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Michel Research Topics

Disease

72	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 05/2002
24	Hemorrhage 07/2022 - 06/2005
21	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 07/2004
12	Infections 01/2022 - 05/2002
10	Thrombosis (Thrombus) 01/2022 - 08/2008
9	Thrombocytopenia (Thrombopenia) 01/2021 - 11/2002
8	Neutropenia 01/2022 - 07/2004
8	Cytopenia 12/2021 - 10/2009
7	COVID-19 04/2022 - 01/2020
7	Neoplasms (Cancer) 01/2022 - 11/2016
7	Evans Syndrome 01/2022 - 07/2004
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2014
5	Hemolysis 01/2022 - 02/2016
5	Hemolytic Anemia 11/2020 - 07/2015
4	Pneumonia (Pneumonitis) 04/2022 - 03/2009
4	Fatigue 01/2022 - 01/2021
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2018 - 11/2002
3	Immune System Diseases (Immune Disorders) 01/2022 - 12/2011
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 10/2009
3	Pure Red-Cell Aplasia 12/2021 - 01/2018
3	Rheumatoid Arthritis 10/2013 - 07/2003
2	Disease Progression 12/2021 - 01/2021
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 01/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2020 - 01/2016
2	Agammaglobulinemia (Hypogammaglobulinemia) 12/2019 - 10/2014
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019 - 12/2008
2	Anemia 01/2019 - 03/2009
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2018 - 07/2003
2	Sepsis (Septicemia) 11/2016 - 01/2016
2	Pain (Aches) 08/2016 - 10/2009
2	Bacterial Infections (Bacterial Infection) 01/2016 - 07/2004
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Embolism and Thrombosis 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Headache (Headaches) 01/2022
1	Rhinitis 01/2022
1	Human Influenza (Influenza) 01/2022
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Iron Overload 12/2021
1	Erythema Infectiosum (Fifth Disease) 12/2021

Drug/Important Bio-Agent (IBA)

54	Inosine Triphosphate (ITP)IBA 01/2022 - 10/2003
22	Rituximab (Mabthera)FDA Link 01/2021 - 02/2008
8	Thrombopoietin ReceptorsIBA 01/2022 - 06/2014
7	AntibodiesIBA 11/2020 - 11/2002
7	AutoantibodiesIBA 08/2015 - 05/2002
6	romiplostim FDA Link 01/2021 - 09/2011
5	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 04/2011
5	Immunoglobulin G (IgG)IBA 01/2022 - 08/2008
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 09/2011
5	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016 - 06/2005
4	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 10/2014
4	Monoclonal AntibodiesIBA 01/2022 - 07/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2008
4	SteroidsIBA 11/2020 - 07/2004
3	AnticoagulantsIBA 07/2022 - 01/2016
3	tocilizumab (atlizumab)FDA Link 04/2022 - 01/2020
3	sutimlimabIBA 01/2022 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2016
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
3	BilirubinIBA 01/2021 - 12/2016
3	Immunoglobulin M (IgM)IBA 11/2020 - 08/2008
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2020 - 07/2007
2	Oxygen (Dioxygen)IBA 04/2022 - 05/2020
2	eltrombopag FDA Link 01/2022 - 06/2013
2	AntigensIBA 01/2021 - 02/2014
2	Circulating Tumor DNAIBA 01/2021 - 04/2019
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
2	Prednisone (Sone)FDA LinkGeneric 01/2017 - 07/2011
2	Morphine (MS Contin)FDA LinkGeneric 08/2016 - 10/2009
2	Antiphospholipid AntibodiesIBA 03/2016 - 08/2008
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2016 - 08/2008
2	Antinuclear AntibodiesIBA 01/2016 - 02/2014
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 01/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 07/2003
1	Janus Kinase InhibitorsIBA 01/2022
1	baricitinibIBA 01/2022
1	Complement C1s (C1 Esterase)IBA 01/2022
1	tofacitinibIBA 01/2022
1	ruxolitinibIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Janus KinasesIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021
1	Biological ProductsIBA 12/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2021
1	daratumumabIBA 12/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	belimumabIBA 01/2021
1	palbociclibIBA 01/2021
1	Erythropoietin FDA Link 01/2021

Therapy/Procedure

20	Therapeutics 07/2022 - 07/2004
10	Splenectomy 01/2022 - 07/2004
2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 11/2020
2	Off-Label Use 01/2022 - 10/2019
2	Critical Care (Surgical Intensive Care) 05/2020 - 08/2016
2	Immunotherapy 01/2020 - 01/2019
2	Aftercare (After-Treatment) 06/2005 - 07/2004
1	Erythrocyte Transfusion 12/2021
1	Emergency Treatment 01/2021